Furthermore, the treatment of NSCLC cells with specific AKT inhibitors (MK2206 or LY294002) strongly impairs AKT phosphorylation, and thus, the spheroid-forming capability of CSCs [129]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.